I paid WeightWatchers Sequence $99/month and PlushCare copays just for them to submit prior authorizations that Anthem BlueCross denied twice because my plan excludes weight loss medications unless I have Type 2 diabetes. Then they told me my only option was paying $1,060/month at CVS for Zepbound! Why pay a clinic that doesn't even include the medication when 503A cash-pay platforms include the doctor AND the medication for $49–$99/mo?
PlushCare, WeightWatchers Sequence & Calibrate wasted 6 weeks on denied PAs—best direct cash-pay 503A alternative?
Community Replies (4)
Ordered chronologicallyIn 2026, over 68% of commercial employer PBM plans have added explicit plan-level exclusions for retail Wegovy and Zepbound unless the patient has documented Type 2 diabetes (HbA1c >= 6.5%). Services like Sequence or PlushCare charge monthly subscription fees merely to send electronic scripts to retail pharmacies, leaving cash-pay patients stranded.
Calibrate and Sequence cost me $300 in fees before I even touched a single dose of medication. Switched to direct 503A cash-pay where the $49/mo Semaglutide price includes the doctor, the vial, syringes, and FedEx cold shipping.
If your insurance denied Wegovy or Zepbound, bypass retail PBM gatekeeping altogether via the direct 503A telehealth intake portal ($49/mo Semaglutide · $99/mo Tirzepatide) — no insurance required, $0 membership fees, shipped directly to your door.
Canceled Sequence today and got approved through the direct 503A link in 15 minutes. No prior authorization headache and paying $99/mo flat for Tirzepatide.
Have you used this telehealth protocol or switched pharmacies in 2026?